You can go to the official website of the China Securities Regulatory Commission to check the specific listing time, and we have not searched for the listing time of Shimai Medical
Shimai Medical is a leading international company focusing on the research and development of innovative devices in the cardiovascular and respiratory fields, covering major diseases such as high blood pressure, heart failure, severe asthma and arrhythmia. diseases. We have a rich product pipeline with the world's first Renal Nerve Labeling/Ablation System for the treatment of hypertension and Bronchial Radiofrequency Ablation System for the treatment of severe asthma as the first-to-market products. Solid domestic and overseas cooperation resources, with long-term and close cooperation with top cardiovascular authorities/industry in the U.S., Europe and Australia. R&D of disruptive and innovative products with Coridea***, a renowned incubation gas pedal at Hopkins University in the US. The founder of the company, Prof. Wang Jie, is a world-renowned expert in heart failure and has been engaged in cardiovascular disease research for many years. He is one of the first scholars to introduce interventional cardiovascular devices into China for development and production, and has led the research and development of a number of products that had been successfully marketed.